The Wall Street Journal recently highlighted former Dana grantee Kevin Tracey’s latest research. The July 8th article, “The Future of Bioelectronic Medicine,” detailed Tracey’s newly published study, which is the first in-human investigation of implanted electronic devices as a treatment for rheumatoid arthritis. Rheumatoid arthritis (RA) is a disorder that occurs when the body’s immune system mistakenly attacks healthy tissue, causing chronic swelling, inflammation, and joint pain. The drugs currently used to manage the disease are not always effective, leaving many patients looking for other treatment options. Continue reading
“What makes us curious? What makes us play with our environment and investigate it? Why are some people more curious than others—and why does my own curiosity wax and wane over time?” These are questions Dana Foundation grantee R. Alison Adcock has asked herself since she was child, and which have led her to focus her scientific research on motivation.
Early last week, the MacArthur Foundation announced the 2015 MacArthur Fellows. Former Dana grantee Beth Stevens was among the 24 recipients. According to MacArthur President Julia Stasch, the award goes to individuals who are “shedding light and making progress on critical issues, pushing the boundaries of their fields, and improving our world in imaginative, unexpected ways.” The fellowship, colloquially known as the MacArthur ‘genius grant,’ comes with a $625,000 ‘no-strings-attached’ stipend to allow recipients to “advance their expertise [and] engage in bold new work.”
“Allowing children to fail, to think they’re ‘dumb,’ is no longer acceptable,” said Dana Alliance member Sally Shaywitz at a recent Capitol Hill briefing on what neuroscience can tell us about educating special needs children.
Shaywitz, co-director of the Yale Center for Dyslexia and Creativity, joined fellow panelists Dana Alliance member Martha Denckla and Damien Fair for a discussion that addressed the importance and the difficulty of early detection of learning disorders such as dyslexia and attention deficit hyperactivity disorder (ADHD). As reported by the American Association for the Advancement of Science (AAAS):
Last month’s Capitol Hill briefing on “Marijuana and the Brain” was the latest in a series hosted by the American Association for the Advancement of Science (AAAS) and sponsored by the Dana Foundation. These sessions are designed to educate Congressional members and their staffs about topical issues in neuroscience, and are open to the public.